|
Español
English
|
Dadun >
Depósito Académico >
Clínica Universidad de Navarra >
Urología >
DA - CUN - Urología - Artículos de revista >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10171/22448
|
| Title: | Respuesta y supervivencia libre de progresión en tumores vesicales en estadiosT2-T4 tratados con tratamiento trimodal de conservación vesical |
| Other Titles: | Response and progression-free survivalinT2toT4 bladder tumors treated with trimodality therapy with bladder preservation |
| Author(s) : | Rincon-Mayans, A. (Anibal) Rosell, D. (David) Zudaire, J.J. (Juan Javier) Rioja-Zuzau, J. (Jorge) Barba, J.F. (Javier Fermín) Tolosa-Eizaguirre, E. (Egoitz) Romero-Vargas, L. (Luis) Pascual-Piedrola, J.I. (Juan Ignacio) |
| Issue Date: | 2010 |
| Publisher: | Elsevier España |
| Citation: | Rincon Mayans A, Rosell Costa D, Zudaire Bergera JJ, Rioja Zuazu J, Barba Abad J, Tolosa Eizaguirre E, et al. Respuesta y supervivencia libre de progresión en tumores vesicales en estadiosT2-T4 tratados con tratamiento trimodal de conservación vesical. Actas Urol Esp 2010 Oct;34(9):775-780 |
| Keywords: | Bladder cancer Quimiotherapy Radiotherapy |
| Abstract: | Objective: Toevaluatetheresponseandthefree-survivalprogressioninpacientsdiagnosed
of invasivebladdercancerwhohavebeentreatedwithtransurethralresection,
chemotherapyandradiotherapy.Thismultimodaltreatmentiscomparedwithanot
random serieofpatientstreatedbyradicalcistectomy.
Material andmethods: Retrospectiveanalysisof43casesofinvasivebladdercancertreated
with twoschemesofbladderpreservationbetween1994–2007.Theyarecomparedwith145
cases treatedwithradicalcistectomyinthesameperiodoftime.
Pronosticvariablesincludedinthestudyareclinicalstage,gradeofdifferentiation,
presence ofureteralobstruction,chemotherapymodality,radiotherapydosesandp53and
ki-67 expression.
Results: Meanandmediantimeare51and39monthsinpatientswithmultimodal
treatment.Completeresponseisachievedin72%ofcasestreatedwithbladder
preservation.Ureteralobstructionisaprognosticfactor(OR:7,3;p:0,02).72%patientswith
complete responsemantainitattheendofthestudy.Noneofanalyzedvariablesare
predictors ofmaintenanceoftheresponse.
Survivalrateswithaintactbladderwere6977% and6177% atthreeandfiveyears.
Radiotherapydosesgreaterthan60Gy(OR:6,1;po0,001) andtheabsenceofureteral
obstruction (OR:7,5;po0,002) werepronosticvariables.
Free-survivalinpatientswithcompleteresponsewas8077% and58710% atthreeand
five years.
At theendofthestudy,53,5%ofpatientshadaintactbladderandfree-disease.
Inthesameperiodoftime,145radicalcistectomieswereperformedduetomuscleinvasive
bladdercancer.Meanandmediantimeinthisgroupwere29and18monthsrespectively.
Stadisticalanalysisrevealsaworseclinicalstageinthegroupofpatientstreatedwith
multimodaltreatment(p:0.01).
Free-survivalwas7275% and6377%at3and5yearsinthegroupofradical
cistectomies.Therewasnotstadisticalsignificantdifferencesbetweencistectomiesand
bladderpreservation.
Conclusions: Patientstreatedwithbladderpreservationhaveafree-survivalsimilartothose
tretedwithradicalcistectomy.Radiotherapy doses greaterthan60Gyandabsenceofureteral
obstructionwerefree-survivalprognosticvariables. |
| URI: | http://hdl.handle.net/10171/22448 |
| Publisher version (URL): | http://dx.doi.org/10.1016/j.acuro.2010.04.008 |
| Appears in Collections: | DA - CUN - Urología - Artículos de revista
|

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|